Is CLXT or JNJ a better dividend investment in 2026?

CLXT currently yields 31.75% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: CLXT offers higher current income.

What is the dividend yield difference between CLXT and JNJ?

CLXT has a forward dividend yield of 31.75% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 28.39 percentage points.

Home › Compare › CLXT vs JNJ

CLXT vs JNJ: Dividend Comparison 2026

CLXT yields 31.75% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CLXT wins by $126.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CLXT

● Live price

31.75%

Share price

$6.30

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$146.3K

Annual income

$20,332.14

Full CLXT calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — CLXT vs JNJ

📍 CLXT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CLXT	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CLXT + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CLXT pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLXT

Annual income on $10K today (after 15% tax)

$2,698.41/yr

After 10yr DRIP, annual income (after tax)

$17,282.32/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, CLXT beats the other by $16,578.71/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLXT + JNJ for your $10,000?

CLXT: 50%JNJ: 50%

100% JNJ50/50100% CLXT

Portfolio after 10yr

$83.2K

Annual income

$10,579.96/yr

Blended yield

12.72%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CLXT

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-4.9

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLXT buys

JNJ buys

No recent congressional trades found for CLXT or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCLXTJNJ

Forward yield	31.75% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$146.3K ✓	$20.0K
Annual income after 10y	$20,332.14 ✓	$827.78
Total dividends collected	$102.0K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: CLXT vs JNJ ($10,000, DRIP)

Year	CLXT Portfolio	CLXT Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$13,875	$3,174.60	$10,676	$355.77	+$3.2K → CLXT
2	$18,962	$4,116.48	$11,407	$389.39	+$7.6K → CLXT
3	$25,548	$5,257.91	$12,198	$426.53	+$13.3K → CLXT
4	$33,956	$6,620.46	$13,056	$467.62	+$20.9K → CLXT
5	$44,557	$8,223.86	$13,987	$513.12	+$30.6K → CLXT
6	$57,761	$10,085.28	$14,998	$563.56	+$42.8K → CLXT
7	$74,023	$12,218.70	$16,098	$619.52	+$57.9K → CLXT
8	$93,839	$14,634.31	$17,295	$681.69	+$76.5K → CLXT
9	$117,746	$17,338.22	$18,599	$750.82	+$99.1K → CLXT
10	$146,321	$20,332.14	$20,022	$827.78	+$126.3K → CLXT

CLXT vs JNJ: Complete Analysis 2026

CLXT — Stock

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Full CLXT Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this CLXT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLXT vs SCHD CLXT vs JEPI CLXT vs O CLXT vs KO CLXT vs MAIN CLXT vs ABBV CLXT vs MRK CLXT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.